Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L5 pseudogene 35 (RPL5P35) is classified as a processed pseudogene in the human genome. It shares sequence similarity with the protein-coding ribosomal protein L5 (RPL5) gene but does not encode a functional protein. Like other pseudogenes, RPL5P35 is considered nonfunctional and is not implicated in direct biological functions or disease roles. Consequently, it is not used as a therapeutic target, biomarker, or safety concern in pharmacology or clinical research.
None (No mechanisms of action as this pseudogene does not code for a protein)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L5 pseudogene 35 (RPL5P35).